Filing Details
- Accession Number:
- 0001127855-10-000209
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-06-02 13:00:00
- Reporting Period:
- 2010-05-28
- Filing Date:
- 2010-06-02
- Accepted Time:
- 2010-06-02 18:03:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1123695 | Imarx Therapeutics Inc | IMRX | Pharmaceutical Preparations (2834) | 860974730 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1489800 | Richard Joseph Takats | 99 Navajo Lane Topanga CA 90290 | Senior Exec. Vp (Marketing) | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-05-28 | 25,542,784 | $0.01 | 27,850,247 | No | 4 | P | Indirect | JRT Productions, Inc. |
$200,000 Promissory Note | Disposition | 2010-05-28 | 0 | $0.00 | 0 | No | 4 | S | Indirect | JRT Productions, Inc. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | JRT Productions, Inc. |
No | 4 | S | Indirect | JRT Productions, Inc. |
Footnotes
- JRT Productions, Inc., a corporation owned 100% by the reporting person, gave notice of its election to convert a Promissory Note principal amount of $200,000 payable to JRT by the Company into shares of the Company's common stock. Pursuant to the terms of the note, the conversion price was calculated as the average three trading prices of the shares of Company common stock on the three trading days preceding the date of conversion.
- The shares will be issued to JRT Productions, Inc., following an amendment to the Company's certificate of incorporation resulting in an increase in the authorized number of shares of common stock of the Company. The amendment is expected to be approved by the Company's shareholders in July 2010.